Polio, also known as poliomyelitis, is a highly contagious viral disease that affects the nervous system and can cause paralysis and even death. It was once one of the most feared diseases of the 20th century, but thanks to the development of a vaccine, it has been largely eradicated in the developed world. However, it is still a threat in some parts of the world, and it is important for doctors to be aware of the risks and know how to diagnose and treat it.
Polio has been around for thousands of years, with evidence of the disease dating back to ancient Egypt. However, it was not until the 20th century that it became a major public health concern. In the 1940s and 1950s, polio outbreaks were common in the United States and Europe, with thousands of cases being reported each year. The disease was particularly devastating to children, as it could cause paralysis and even death.
In the 1950s, the development of a polio vaccine became a major priority for public health officials. The vaccine was developed by Jonas Salk and tested in 1954. It was found to be effective in preventing polio, and within a few years it was widely available. By the 1960s, polio had been largely eradicated in the United States and Europe.
In 1988, the World Health Organization (WHO) launched a global effort to eradicate polio. This effort has been largely successful, with the number of cases dropping significantly in the last three decades. In 2020, there were only 33 reported cases of polio worldwide, a 99.9% reduction from the estimated 350,000 cases in 1988.
Despite the success of global eradication efforts, polio is still a threat in some parts of the world. In 2020, the majority of cases were reported in Afghanistan and Pakistan, with a few cases reported in Nigeria, Ethiopia, and Somalia. The virus is particularly dangerous in areas with poor sanitation and limited access to health care, as it can spread quickly and cause serious complications.
Polio is a virus that can be spread through contact with an infected person or contaminated objects. It is most commonly spread through person-to-person contact, but it can also be spread through contaminated food and water. Symptoms of polio include fever, headache, fatigue, and muscle pain. In severe cases, it can cause paralysis and even death. Diagnosis of polio is typically made through laboratory tests, such as a stool sample or throat swab. Treatment is supportive and focuses on preventing complications and managing symptoms. There is no specific treatment for polio, but immunization is the most effective way to prevent it.
Polio is a highly contagious virus that can cause paralysis and even death. It was once a major public health concern, but thanks to the development of a vaccine, it has been largely eradicated in the developed world. However, it is still a threat in some parts of the world, and it is important for doctors to be aware of the risks and know how to diagnose and treat it. Immunization is the most effective way to prevent polio, and it is important for doctors to encourage their patients to get vaccinated.
1.
Advances in "next generation" photoactive cancer therapy
2.
Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCL
3.
The American College of Physicians updated its recommendations for colorectal cancer screening.
4.
Optimizing Sequencing of BCMA-Directed Therapies in Myeloma
5.
According to a study, patients with ovarian cancer who undergo aggressive surgery have a 70% lower chance of dying.
1.
Quality of Life Using Precision Functional Recovery After Organ-Preserving Interventions
2.
Cancer Memory: A Persistent Threat to Tumor Recurrence and Metastasis
3.
Neoadjuvant Abraxane Chemotherapy Combined with Neutrophil Cytopharmaceuticals and Radiotherapy
4.
Modern Developments in Oncology for Specialists
5.
Can We Repurpose BV-CHP for Better Outcomes in Peripheral T-Cell Lymphoma?
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
1.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
2.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
3.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
4.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
5.
Navigating the Complexities of Ph Negative ALL - Part XII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation